http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35290515

Outgoing Links

Predicate Object
contentType Journal Article|Retracted Publication
endingPage 8
issn 1748-6718
1748-670X
pageRange 7864114-8
publicationName Computational and Mathematical Methods in Medicine
startingPage 7864114
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b98e6071e8694eb16761fa619e98e5bf
bibliographicCitation Wang X, Huang Y, Yang Z, Yang Y, Wei F, Yan M, Li F. Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer. Computational and Mathematical Methods in Medicine. 2022 Sep 17;2022():1–8. doi: 10.1155/2022/7864114.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bab49f3fc9f35facd67c20c0833e1f7e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acf7bbc763054384340d677e869985cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fe9628959f3e82f44a22ee2f1190645
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dc227b9be4b69f72c214f119e00a02f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1268-3702
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea1576d63e09ea2de8714e54ca240345
date 2022-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/36164613
https://pubmed.ncbi.nlm.nih.gov/PMC9509258
https://doi.org/10.1155/2022/7864114
isPartOf https://portal.issn.org/resource/ISSN/1748-670X
https://portal.issn.org/resource/ISSN/1748-6718
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34878
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer
discusses http://id.nlm.nih.gov/mesh/M0007520
http://id.nlm.nih.gov/mesh/M000636643
http://id.nlm.nih.gov/mesh/M0000967
http://id.nlm.nih.gov/mesh/M0287377
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0000268
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D004791Q000009
http://id.nlm.nih.gov/mesh/D000634Q000627
http://id.nlm.nih.gov/mesh/D000178Q000627
http://id.nlm.nih.gov/mesh/D001943Q000201
http://id.nlm.nih.gov/mesh/D018719Q000378
http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D000178Q000009
http://id.nlm.nih.gov/mesh/D000634Q000009
http://id.nlm.nih.gov/mesh/D004791Q000627
http://id.nlm.nih.gov/mesh/D018719Q000037
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000069287Q000009
http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D000069287Q000627
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453

Total number of triples: 54.